Cheung Nai-Kong V 13D/13G Filings for Y-mAbs Therapeutics, Inc. (YMAB)

Cheung Nai-Kong V 13D and 13G filings for Y-mAbs Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-08-27
4:54 pm
Sale		 2019-09-10 13G Y-mAbs Therapeutics, Inc.
YMAB		 Cheung Nai-Kong V 1,897,132
4.740%		 -529,268decrease
(-21.81%)		 Filing
2020-08-25
6:22 pm
Purchase		 2018-08-24 13G Y-mAbs Therapeutics, Inc.
YMAB		 Cheung Nai-Kong V 2,426,400
8.640%		 2,426,400increase
(New Position)		 Filing